Related Experiment Video
Updated: Apr 30, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Inflammatory bowel disease and celiac disease: overlaps and differences
Virginia Pascual1, Romina Dieli-Crimi1, Natalia López-Palacios1
1Virginia Pascual, Romina Dieli-Crimi, Luz María Medrano, Concepción Núñez, UGC de Inmunología, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
This review explores shared genetic and pathogenic factors in immune-mediated diseases, focusing on inflammatory bowel disease (IBD) and celiac disease (CeD). Understanding these overlaps aids in diagnosing and treating chronic intestinal inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Genetics
Background:
- Immune-mediated diseases often share common genetic underpinnings and pathogenic pathways.
- Inflammatory bowel disease (IBD) and celiac disease (CeD) are two autoimmune conditions targeting the bowel with chronic intestinal inflammation.
- The precise etiology and immunopathogenesis of IBD and CeD remain incompletely understood, involving complex genetic and environmental interactions.
Purpose of the Study:
- To review and synthesize recent findings on the shared genetic basis and pathogenesis of immune-mediated diseases.
- To examine the overlaps in disease characteristics, particularly focusing on IBD and CeD as models of chronic intestinal inflammation.
- To highlight the known triggers in celiac disease and the multifactorial origins of IBD.
Main Methods:
- Literature review of recent findings on immune-mediated diseases.
- Comparative analysis of genetic and pathogenic overlaps between IBD and CeD.
- Examination of environmental and host factors contributing to disease development.
Main Results:
- Evidence suggests a common genetic basis and partially shared pathogenesis across various immune-mediated diseases.
- IBD and CeD exhibit significant overlaps in chronic intestinal inflammation, despite differing known triggers and specific pathogenic mechanisms.
- Genetic and environmental factors, including immune response dysregulation and microbiota interactions, are crucial in IBD and CeD pathogenesis.
- Clinical heterogeneity in IBD and CeD is observed, with variations in phenotype and age of onset, particularly in adults.
Conclusions:
- Shared genetic and pathogenic mechanisms contribute to immune-mediated diseases, including IBD and CeD.
- Further research into these overlaps can improve understanding and management of chronic intestinal inflammatory conditions.
- Identifying specific triggers and pathways is essential for developing targeted therapies for IBD and CeD.
More Related Videos
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
07:39Author Spotlight: Investigating the Effects of Compounds on Intestinal Tissue Using 3D Human Cell Line Models
Published on: September 1, 2023
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis